Hepatic artery chronomodulated infusion of irinotecan, 5-fluorouracil and oxaliplatin against liver metastases in heavily pretreated patients with colorectal cancer.

被引：0
|
作者：
Bouchahda, M
Tanaka, K
Adam, R
Giacchetti, S
Brézault-Bonnet, C
Gholam, D
Kunslinger, F
Castaing, D
Jasmin, C
Lévi, FA
机构：
[1] Hop Paul Brousse, Villejuif, France
[2] INSERM, E0354, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3722
引用
收藏
页码：299S / 299S
页数：1
相关论文
共 50 条
  • [31] METABOLICALLY ACTIVE LIVER METASTASES TREATED BY 5-FLUOROURACIL HEPATIC ARTERY INFUSION
    EARLE, E
    BUTTS, D
    HOAGLIN, LL
    CANCER, 1970, 25 (05) : 1170 - &
  • [32] Intravenous weekly high-dose infusion of 5-fluorouracil and folinic acid in previously heavily pretreated patients with metastatic colorectal cancer.
    Piringer, Gudrun
    Huber, Verena
    Burgstaller, Sonja
    Weninger, Martin
    Karrer, Andreas
    Mayrbaeurl, Beate
    Thaler, Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [33] Chronomodulated infusion of irinotecan, 5-fluorouracil and folinic acid and hematological toxicity in patients with advanced gastrointestinal cancer
    Merkel, U
    Farker, K
    Wedding, U
    Hippius, M
    Höffken, K
    Hoffmann, A
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A45 - A45
  • [34] Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer.
    deGramont, A
    Tournigand, C
    Louvet, C
    Andre, T
    Molitor, JL
    Raymond, E
    Moreau, S
    Vignoud, J
    LeBail, N
    Krulik, M
    REVUE DE MEDECINE INTERNE, 1997, 18 (10): : 769 - 775
  • [35] Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer -: Clinical implications
    Lentz, F
    Tran, A
    Rey, E
    Pons, G
    Tréluyer, JM
    AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (01) : 21 - 33
  • [36] Bimonthly Chemotherapy with Oxaliplatin, Irinotecan, Infusional 5-Fluorouracil/Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with Irinotecan- or Oxaliplatin-Based Chemotherapy
    Nobili, S.
    Checcacci, D.
    Filippelli, F.
    Del Buono, S.
    Mazzocchi, V.
    Mazzei, T.
    Mini, E.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 622 - 631
  • [37] Rescue Chemotherapy Using Multidrug Chronomodulated Hepatic Arterial Infusion for Patients With Heavily Pretreated Metastatic Colorectal Cancer
    Bouchahda, Mohamed
    Adam, Rene
    Giacchetti, Sylvie
    Castaing, Denis
    Brezault-Bonnet, Catherine
    Hauteville, Dominique
    Innominato, Pasquale F.
    Focan, Christian
    Machover, David
    Levi, Francis
    CANCER, 2009, 115 (21) : 4990 - 4999
  • [38] A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
    Feng, Ai-Wei
    Guo, Jian-Hai
    Gao, Song
    Kou, Fu-Xin
    Liu, Shao-Xing
    Liu, Peng
    Chen, Hui
    Wang, Xiao-Dong
    Xu, Hai-Feng
    Cao, Guang
    Zhu, Xu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Vasopressin selectively increases 5-fluorouracil uptake by colorectal liver metastases following hepatic artery bolus infusion
    Dietz, DW
    Casillas, S
    Jones, SC
    Milsom, JW
    JOURNAL OF SURGICAL RESEARCH, 1998, 77 (02) : 150 - 156
  • [40] Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer
    Kern, W
    Beckert, B
    Lang, N
    Stemmler, J
    Beykirch, M
    Stein, J
    Goecke, E
    Waggershauser, T
    Braess, J
    Schalhorn, A
    Hiddemann, W
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 599 - 603
12345